The board meeting for Atara Biotherapeutics Inc is scheduled for today, for the purpose of Atara Biotherapeutics Inc First Quarter Earnings Results for 2026See details
Atara Biotherapeutics Inc has a share price target of US$ 12, revenue growth forecast of -86.0%, and profit growth estimate of -98.1% for FY26, based on top 4 analyst calls.